Indrayani Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs)
Indrayani Biotech Ltd · Financial Result · 07 Oct 2026, 11:38 pm
Indrayani Biotech Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 3,771 (+29.6% YoY | -0.2% QoQ) ■ EBITDA: 147 (-32.7% YoY | -33.7% QoQ) ■ EBITDA Margin (%): 3.9 (-360 bps YoY | -197 bps QoQ) ■ PAT: 26.2 (+156.1% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.06 (+200.0% YoY | Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Indrayani Biotech Ltd
- Annual Report of the Company for the Financial year ended March 31, 2026. · 07 Nov 2026
- Annual Report of the Company for the Financial year ended March 31, 2026. · 07 Nov 2026
- Submission of Notice of the 34th Annual General Meeting will be held on November 30, 2026 at 03.00 PM IST through VC/OAVM · 07 Nov 2026
- Intimation of Record date for the 34th Annual General Meeting · 07 Nov 2026
- Company has received on Listing Approval from BSE for the Proposed Rights issue. · 06 Nov 2026
- Revised outcome of the Rights Issue Committee held on November 03, 2026 · 04 Nov 2026
- Outcome of the Rights Issue Committee Meeting held on November 03, 2026 · 03 Nov 2026
- Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve 1. Notice of the 34th Annual .... · 03 Nov 2026
